Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4833 Target Snapshot

Reduced folate transporter · SINGLE PROTEIN · Homo sapiens

68Compounds
18Assays
5Approved Drugs
81.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P41440. Use UniProt P41440 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P41440 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Reduced folate transporter as ChEMBL target CHEMBL4833, mapped to UniProt P41440. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Reduced folate transporter
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4833
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P41440
Reduced folate transporter
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Reduced folate transporter is the right protein anchor across sources, using UniProt P41440 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelReduced folate transporter
UniProt AccessionP41440
Component TypeProtein
Sequence Length591 aa

Reduced folate transporter

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Reduced folate transporter, mapped to UniProt P41440. Sequence length is 591 aa.

Mapped IDP41440
Review nameReduced folate transporter
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

5
Approved
Assay Mix

Activity Type Distribution

IC5077.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1201746 9.16 IC50 0.69 Approved
CHEMBL225071 8.2 IC50 6.3 Approved
CHEMBL34259 7.92 IC50 12.0 Approved
CHEMBL4445651 7.7 IC50 20.1 Preclinical
CHEMBL225072 7.62 IC50 23.8 Approved
CHEMBL3409335 7.42 IC50 38.3 Preclinical
CHEMBL3628345 7.27 IC50 54.0 Preclinical
CHEMBL3407519 7.22 IC50 59.8 Preclinical
CHEMBL4538151 7.21 IC50 62.0 Preclinical
CHEMBL3628344 7.2 IC50 62.9 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
1
5.5
10
6.0
12
6.5
8
7.0
5
7.5
2
8.0
0
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PRALATREXATE
CHEMBL1201746
Approved 2009
PEMETREXED
CHEMBL225072
Approved 2004
RALTITREXED
CHEMBL225071
Approved 1996
METHOTREXATE
CHEMBL34259
Approved 1953
Assay Landscape

Assay Landscape

18
Total Assays
27
Tested Compounds
1
Assay Types
Binding — 18 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 17 26 7.0
single protein format 1 1 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine